Literature DB >> 27551243

The Perceived Deficits Questionnaire: Perception, Deficit, or Distress?

Lauren B Strober, Allison Binder, Olga M Nikelshpur, Nancy Chiaravalloti, John DeLuca.   

Abstract

BACKGROUND: Cognitive dysfunction affects approximately 43% to 70% of individuals with multiple sclerosis (MS) and is an important determinant of several functional outcomes in MS and quality of life. Brief neuropsychological test batteries have been developed specifically for use in MS and are widely used to aid clinicians in assessing levels of cognitive impairment in MS. Neuropsychologists and neurologists also frequently use briefer screening measures, such as the Perceived Deficits Questionnaire (PDQ), to assist in determining whether a more extensive neuropsychological evaluation is warranted. However, despite the ease of such measures, the relationship between self-report and objective cognitive impairment has been inconsistent, at best. Moreover, factors such as depression, fatigue, anxiety, and personality have been found to be more related to reports of cognitive difficulties. The purpose of the present study was to clarify the relationship between subjective cognitive concerns and objective cognitive impairment while accounting for related symptoms.
METHODS: We examined the association of self-reported cognitive concerns on the PDQ with objective cognitive measures, as well as depression, anxiety, fatigue, and self-efficacy.
RESULTS: There was no relationship between self-reported cognitive concerns and objective performance. Rather, reports on the PDQ were more correlated with reports of depression, anxiety, fatigue, and self-efficacy.
CONCLUSIONS: Depression and poor self-efficacy can contribute to reports of cognitive difficulties. Effective treatment to improve these factors seems warranted given the impact of perceived cognitive impairment on outcomes in MS and the potential for more accurate self-reports.

Entities:  

Year:  2016        PMID: 27551243      PMCID: PMC4984790          DOI: 10.7224/1537-2073.2015-028

Source DB:  PubMed          Journal:  Int J MS Care        ISSN: 1537-2073


  31 in total

1.  Self-efficacy: toward a unifying theory of behavioral change.

Authors:  A Bandura
Journal:  Psychol Rev       Date:  1977-03       Impact factor: 8.934

2.  The association of illness severity, self-reported cognitive impairment, and perceived illness management with depression and anxiety in a multiple sclerosis clinic population.

Authors:  Kristin Lester; Lara Stepleman; Mary Hughes
Journal:  J Behav Med       Date:  2007-02-23

3.  Self-efficacy as a predictor of self-reported physical, cognitive, and social functioning in multiple sclerosis.

Authors:  Margaret M Schmitt; Yael Goverover; John Deluca; Nancy Chiaravalloti
Journal:  Rehabil Psychol       Date:  2013-12-09

4.  Factors affecting anxiety in multiple sclerosis.

Authors:  A C Garfield; N B Lincoln
Journal:  Disabil Rehabil       Date:  2012       Impact factor: 3.033

5.  Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.

Authors:  R H B Benedict; J A Duquin; S Jurgensen; R A Rudick; J Feitcher; F E Munschauer; M A Panzara; B Weinstock-Guttman
Journal:  Mult Scler       Date:  2008-06-23       Impact factor: 6.312

6.  Self-efficacy predicts self-reported health status in multiple sclerosis.

Authors:  A Riazi; A J Thompson; J C Hobart
Journal:  Mult Scler       Date:  2004-02       Impact factor: 6.312

7.  An exploration of the relationship between perception of control, physical disability, optimism, self-efficacy and hopelessness in multiple sclerosis.

Authors:  Indrani Sinnakaruppan; Kirsty Macdonald; Aileen McCafferty; Paul Mattison
Journal:  Int J Rehabil Res       Date:  2010-03       Impact factor: 1.479

8.  Measuring self-efficacy in people with multiple sclerosis: a validation study.

Authors:  C E Schwartz; L Coulthard-Morris; Q Zeng; P Retzlaff
Journal:  Arch Phys Med Rehabil       Date:  1996-04       Impact factor: 3.966

9.  The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated.

Authors:  R A Marrie; R Horwitz; G Cutter; T Tyry; D Campagnolo; T Vollmer
Journal:  Mult Scler       Date:  2009-01-19       Impact factor: 6.312

10.  University of Washington self-efficacy scale: a new self-efficacy scale for people with disabilities.

Authors:  Dagmar Amtmann; Alyssa M Bamer; Karon F Cook; Robert L Askew; Vanessa K Noonan; Jo Ann Brockway
Journal:  Arch Phys Med Rehabil       Date:  2012-05-07       Impact factor: 3.966

View more
  13 in total

1.  Screening Instruments for the Early Detection of Cognitive Impairment in Patients with Multiple Sclerosis.

Authors:  Sonya Kim; Vance Zemon; Joseph F Rath; MaryAnn Picone; Elizabeth S Gromisch; Heather Glubo; Lucia Smith-Wexler; Frederick W Foley
Journal:  Int J MS Care       Date:  2017 Jan-Feb

2.  In pursuit of full recovery in major depressive disorder.

Authors:  Vicent-Gil M; Serra-Blasco M; Navarra-Ventura G; Trujols J; Balanzá-Martínez V; Portella Mj; Cardoner N
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-09-09       Impact factor: 5.760

3.  Making Sense of the Matrix: A Qualitative Assessment and Commentary on Connecting Psychiatric Symptom Scale Items to the Research Domain Criteria (RDoC).

Authors:  Leslie Citrome; Anissa Abi-Dargham; Robert M Bilder; Ruth A Duffy; Boadie W Dunlop; Philip D Harvey; Diego A Pizzagalli; Carol A Tamminga; Roger S McIntyre; John M Kane
Journal:  Innov Clin Neurosci       Date:  2022 Jan-Mar

4.  Perceived Cognitive Deficits in a Sample of Persons Living With Multiple Sclerosis.

Authors:  Ashley Henneghan; Alexa Stuifbergen; Heather Becker; Vicki Kullberg; Nicole Gloris
Journal:  J Neurosci Nurs       Date:  2017-10       Impact factor: 1.230

5.  Reliability and Validity of a Danish Version of the Multiple Sclerosis Neuropsychological Screening Questionnaire.

Authors:  Tobias Sejbæk; Morten Blaabjerg; Pippi Sprogøe; Mads Ravnborg
Journal:  Int J MS Care       Date:  2018 Jan-Feb

6.  Variables Associated with Self-reported Language Impairment in Multiple Sclerosis: A Regression Analysis.

Authors:  Sarah El-Wahsh; Rob Heard; Hans Bogaardt; Fiona Kumfor; Kirrie J Ballard
Journal:  Int J MS Care       Date:  2021-04-14

7.  Research on cognitive and sociocognitive functions in patients with brain tumours: a bibliometric analysis and visualization of the scientific landscape.

Authors:  Uwe Schlegel; Patrizia Thoma; Milena Pertz; Stoyan Popkirov
Journal:  Neurol Sci       Date:  2020-02-12       Impact factor: 3.307

8.  Cognitive Dysfunction in Asian Patients with Depression (CogDAD): A Cross-Sectional Study.

Authors:  Srisurapanont Manit; Mok Yee Ming; Yang Yen Kuang; Chan Herng-Nieng; Della Constantine D; Zainal Nor Zuraida; Jambunathan Stephen; Amir Nurmiati; Kalita Pranabi
Journal:  Clin Pract Epidemiol Ment Health       Date:  2017-10-31

9.  Into the Moment: Does Mindfulness Affect Biological Pathways in Multiple Sclerosis?

Authors:  Barbara Willekens; Gaetano Perrotta; Patrick Cras; Nathalie Cools
Journal:  Front Behav Neurosci       Date:  2018-05-22       Impact factor: 3.558

10.  Screening for Executive Dysfunction in Late-Life Depression: Utility of Trail Making Test and Self-Report Measures.

Authors:  David Bickford; Ruth T Morin; Dan Catalinotto; R Scott Mackin; J Craig Nelson
Journal:  Am J Geriatr Psychiatry       Date:  2018-06-25       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.